Saturday, July 11, 2026

Drug profile · INN

conbercept

conbercept is a vascular endothelial growth factor a inhibitor.

NMPA: clinical trials
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — conbercept
Class
Route
Patents
0
Programs
1
Data quality
0.70

Quick answer

conbercept is a vascular endothelial growth factor a inhibitor.

Key facts

INN conbercept
Mechanism Vascular endothelial growth factor A inhibitor
Target Placenta growth factor

Mechanism of action

Vascular endothelial growth factor A inhibitor

Primary target: Placenta growth factor

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. conbercept Approved · Hospital Authority · Polypoidal Choroidal Vasculopathy

Related & competitor drugs

  1. aflibercept Sensory organs (S01)
  2. aflibercept-abzv Placenta growth factor inhibitor
  3. aflibercept-ayyh Placenta growth factor inhibitor
  4. aflibercept-jbvf Placenta growth factor inhibitor
  5. aflibercept-mrbb Placenta growth factor inhibitor
  6. aflibercept-yszy Placenta growth factor inhibitor

Frequently asked questions

What is conbercept?

conbercept is a vascular endothelial growth factor a inhibitor.